Global provider of cardiac safety, Banook Group, opens subsidiary in the Neomed Institute, Montreal, Canada
The Banook Group, global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, has opened a new subsidiary at the Neomed Institute, a centre of excellence in clinical research, in Montreal, Canada.
Pascal Voiriot, Chair of the Banook Group, said: “Our new location will enable us to closely observe technology improvements, forge new partnerships and provide more opportunities to attend key industry events.”
Philippe Walker, General Manager R&D and CSO. “The arrival of the Banook Group inside the Neomed Institute is a win-win situation; Neomed gets a robust service provider in clinical trials and the Banook Group has access to our incredible know-how on the North America biotechnology market.”